Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med, 2006,354(2):166–178
PubMed
Article
CAS
Google Scholar
Zwaan CM, Kaspers GJ, Pieters R, et al. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood, 2000,96(8):2879–2886.
PubMed
CAS
Google Scholar
Kaspers GJ, Veerman AJ, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood, 1997,90(7): 2723–2729
PubMed
CAS
Google Scholar
Yamada S, Hongo T, Okada S, et al. Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia. Leukemia, 2001,15(12):1892–1897
PubMed
CAS
Google Scholar
Okada S, Hongo T, Yamada S, et al. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia. Br J Haematol, 2003,123(5):802–809
PubMed
Article
CAS
Google Scholar
Dubbers A, Wurthwein G, Muller HJ, et al. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity. Br J Haematol, 2000,109(2):427–429
PubMed
Article
CAS
Google Scholar
Muller HJ, Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol, 1998,28(2):97–113
PubMed
Article
CAS
Google Scholar
Miller HK, Salser JS, Balis ME. Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy. Cancer Res, 1969,29(1):183–187
PubMed
CAS
Google Scholar
Ohnuma T, Holland JF, Freeman A, et al. Biochemical and pharmacological studies wih asparaginase in man. Cancer Res, 1970,30(9):2297–2305
PubMed
CAS
Google Scholar
Richards NG, Schuster SM. Mechanistic issues in asparagine synthetase catalysis. Adv Enzymol Relat Areas Mol Biol, 1998,72N:145–198
Google Scholar
Li BS, Gu LJ, Luo CY, et al. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to L-asparaginase. Leukemia, 2006, 20(12):2199–2201
PubMed
Article
CAS
Google Scholar
Appel IM, den Boer ML, Meijerink JP, et al. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia. Blood, 2006,107(11): 4244–4249
PubMed
Article
CAS
Google Scholar
Holleman A, den Boer ML, Kazemier KM, et al. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood, 2003,102(13):4541–4546
PubMed
Article
CAS
Google Scholar
Leslie M, Case MC, Hall AG, et al. Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia. Br J Haematol, 2006,132(6):740–742
PubMed
Article
CAS
Google Scholar
Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by L-asparaginase, Br J Haematol, 2005,130(6):860–868
PubMed
Article
CAS
Google Scholar
Aslanian AM, Kilberg MS. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells. Biochem J, 2001,358(Pt 1):59–67
PubMed
Article
CAS
Google Scholar
Haskell CM, Canellos GP. L-asparaginase resistance in human leukemia—asparagine synthetase. Biochem Pharmacol, 1969,18(10):2578–2580
PubMed
Article
CAS
Google Scholar
Kiriyama Y, Kubota M, Takimoto T, et al. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia, 1989,3(4): 294–297
PubMed
CAS
Google Scholar
Codegoni AM, Biondi A, Conter V, et al. Human monocytic leukemia expresses low levels of asparagine synthase and is potentially sensitive to L-asparaginase. Leukemia, 1995,9(2):360–361
PubMed
CAS
Google Scholar
Barbosa-Tessmann IP, Chen C, Zhong C, et al. Activation of the human asparagine synthetase gene by the amino acid response and the endoplasmic reticulum stress response pathways occurs by common genomic elements. J Biol Chem, 2000,275(35):26976–26985
PubMed
CAS
Google Scholar
Jousse C, Averous J, Bruhat A, et al. Amino acids as regulators of gene expression: molecular mechanisms. Biochem Biophys Res Commun, 2004,313(2):447–452
PubMed
Article
CAS
Google Scholar
Fafournoux P, Bruhat A, Jousse C. Amino acid regulation of gene expression. Biochem J, 2000,351(Pt 1N):1–12
PubMed
Article
CAS
Google Scholar
Hutson RG, Kitoh T, Moraga Amador DA, et al. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol, 1997,272(5 Pt 1):C1691–C1699
PubMed
CAS
Google Scholar
Guerrini L, Gong SS, Mangasarian K, et al. Cis- and trans-acting elements involved in amino acid regulation of asparagine synthetase gene expression. Mol Cell Biol, 1993,13(6):3202–3212
PubMed
CAS
Google Scholar
Greco A, Gong SS, Ittmann M, et al. Organization and expression of the cell cycle gene, ts11, that encodes asparagine synthetase. Mol Cell Biol, 1989,9 (6):2350–2359
PubMed
CAS
Google Scholar
Hongo S, Sakagami H, Sato T. Decrease in asparagine synthetase activity during cell differentiation of mouse and human leukemia cell lines. Leukemia, 1990,4(10): 708–711
PubMed
CAS
Google Scholar
Richards NG, Kilberg MS. Asparagine synthetase chemotherapy. Annu Rev Biochem, 2006,75N:629–654
Article
Google Scholar
Fine BM, Kaspers GJ, Ho M, et al. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia. Cancer Res. 2005,65(1):291–299
PubMed
CAS
Google Scholar
Palacin M, Estevez R, Bertran J, et al. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev, 1998,78(4):969–1054
PubMed
CAS
Google Scholar
Iwamoto S, Mihara K, Downing JR, et al. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest, 2007,117(4): 1049–1057
PubMed
Article
CAS
Google Scholar
Rubartelli A, Sitia R. Interleukin 1 beta and thioredoxin are secreted through a novel pathway of secretion. Biochem Soc Trans, 1991,19(2):255–259
PubMed
CAS
Google Scholar
Rubartelli A, Bajetto A, Allavena G, et al. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem, 1992,267(34): 24161–24164
PubMed
CAS
Google Scholar
Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol, 1992,151(1):81–93
PubMed
Article
CAS
Google Scholar
Mehul B, Hughes RC. Plasma membrane targetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion. J Cell Sci, 1997,110( Pt10):1169–1178
PubMed
CAS
Google Scholar
Chang HC, Samaniego F, Nair BC, et al. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS, 1997,11(12): 1421–1431
PubMed
Article
CAS
Google Scholar
Tanudji M, Hevi S, Chuck SL. Improperly folded green fluorescent protein is secreted via a non-classical pathway. J Cell Sci, 2002,115(Pt 19):3849–3857
PubMed
Article
CAS
Google Scholar